198 related articles for article (PubMed ID: 34871181)
1. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
Siedner MJ; Boucau J; Gilbert RF; Uddin R; Luu J; Haneuse S; Vyas T; Reynolds Z; Iyer S; Chamberlin GC; Goldstein RH; North CM; Sacks CA; Regan J; Flynn JP; Choudhary MC; Vyas JM; Barczak AK; Lemieux JE; Li JZ
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34871181
[TBL] [Abstract][Full Text] [Related]
2. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
mSphere; 2021 May; 6(3):. PubMed ID: 34011679
[TBL] [Abstract][Full Text] [Related]
3. Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation.
Alshukairi AN; Al-Omari A; Al-Tawfiq JA; El-Kafrawy SA; El-Daly MM; Hassan AM; Faizo AA; Alandijany TA; Dada A; Saeedi MF; Alhamlan FS; Al Hroub MK; Qushmaq I; Azhar EI
J Infect Public Health; 2022 Jun; 15(6):628-630. PubMed ID: 35576779
[TBL] [Abstract][Full Text] [Related]
4. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
[TBL] [Abstract][Full Text] [Related]
5. Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk.
Leitão IC; Calil PT; Galliez RM; Moreira FRR; Mariani D; Castiñeiras ACP; da Silva GPD; Maia RA; Corrêa IA; Monteiro FLL; de Souza MRM; Gonçalves CCA; Higa LM; de Jesus Ribeiro L; Fonseca VWP; Bastos VC; Voloch CM; Faffe DS; da Costa Ferreira O; Tanuri A; Castiñeiras TMPP; da Costa LJ;
Microbiol Spectr; 2021 Dec; 9(3):e0085521. PubMed ID: 34787498
[TBL] [Abstract][Full Text] [Related]
6. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
[TBL] [Abstract][Full Text] [Related]
8. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
[TBL] [Abstract][Full Text] [Related]
9. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
Plante JA; Machado RRG; Mitchell BM; Shinde DP; Walker J; Scharton D; McConnell A; Saada N; Liu J; Khan B; Campos RK; Johnson BA; Menachery VD; Levine CB; Ren P; McLellan SLF; Plante KS; Weaver SC
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146877
[TBL] [Abstract][Full Text] [Related]
10. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
[TBL] [Abstract][Full Text] [Related]
11. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
[TBL] [Abstract][Full Text] [Related]
12. Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults.
Duan R; Mao Q; Ding X; Qiu Q; Wang P
Immun Inflamm Dis; 2022 Jul; 10(7):e670. PubMed ID: 35759224
[TBL] [Abstract][Full Text] [Related]
13. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
[TBL] [Abstract][Full Text] [Related]
14. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals.
Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG
Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775
[TBL] [Abstract][Full Text] [Related]
15. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
[TBL] [Abstract][Full Text] [Related]
16. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
[TBL] [Abstract][Full Text] [Related]
17. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
[TBL] [Abstract][Full Text] [Related]
18. Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
Kang SW; Park H; Yeun Kim J; Bae JY; Park MS; Kim SH
Vaccine; 2023 Apr; 41(17):2769-2772. PubMed ID: 37003909
[TBL] [Abstract][Full Text] [Related]
19. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms.
Keske Ş; Güney-Esken G; Vatansever C; Beşli Y; Kuloğlu ZE; Nergiz Z; Barlas T; Şencanlı Ö; Kuşkucu MA; Palaoğlu E; Can F; Önder Ergönül
Clin Microbiol Infect; 2023 Feb; 29(2):221-224. PubMed ID: 35853589
[TBL] [Abstract][Full Text] [Related]
20. Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals.
Kandel CE; Banete A; Taylor M; Llanes A; McCready J; Crowl G; Young M; Li AX; Chien E; Yim W; Yip L; Kozak R; McGeer AJ; Mubareka S; Powis JE
Infect Control Hosp Epidemiol; 2023 Jun; 44(6):1002-1004. PubMed ID: 35598890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
